Find clinical trials for Colon Cancer in Pittsburgh, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Colon Cancer trials near Pittsburgh, PA, USA:
(SOC) in participants with untreated T4N0 or Stage III (resectable), defective mismatch repair/ microsatellite instability high (dMMR/MSI-H) colon...
Phase 3
Pittsburgh, Pennsylvania, United States and 262 other locations
To confirm the safety and performance of the da Vinci SP Surgical System, Instruments and Accessories in a complex colorectal procedure such as low a...
Pittsburgh, Pennsylvania, United States and 8 other locations
Dosimetry, Pharmacokinetics, and Preliminary Efficacy of 212Pb-DOTAM-GRPR1 in Adult Participants with Recurrent or Metastatic GRPR-expressing Tumors...
Phase 1
Pittsburgh, Pennsylvania, United States and 7 other locations
in combination with pembrolizumab in patients with select advanced cancers, and to identify the maximum tolerated dose and/or recommended do...
Phase 1
Pittsburgh, Pennsylvania, United States and 18 other locations
to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combinatio...
Phase 1
Pittsburgh, Pennsylvania, United States and 48 other locations
This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor...
Phase 2, Phase 3
Pittsburgh, Pennsylvania, United States and 1060 other locations
chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer....
Phase 3
Pittsburgh, Pennsylvania, United States and 275 other locations
or in combination with other drugs will delay or prevent colorectal cancer from coming back in patients with colorectal cancer who ...
Phase 2
Pittsburgh, Pennsylvania, United States and 8 other locations
with standard chemotherapy for the potential treatment of colorectal cancer that:* has spread to other parts of the body (metastatic);* has ...
Phase 3
Pittsburgh, Pennsylvania, United States and 273 other locations
Study CA239-0006 is an open-label, randomized Phase 3 clinical trial comparing the efficacy of MRTX849 administered in combination with cetuximab ver...
Phase 3
Pittsburgh, Pennsylvania, United States and 427 other locations
Clinical trials
Research sites
Resources
Legal